natgillin/translations-raw huggingface dataset:
Det anbefales at nedsætte dosis ved behandling af patienter med moderat nedsat leverfunktion (Child-Pugh klasse B) (f.eks. fra startdosis på 5 mg 2 gange dagligt til 2 mg 2 gange dagligt).
A dose decrease is recommended when administering axitinib to patients with moderate hepatic impairment (Child-Pugh class B) (e.g. the starting dose should be reduced from 5 mg twice daily to 2 mg twice daily).
Det anbefales at nedsætte eller øge dosis på baggrund af individuel sikkerhed og tolerabilitet.
Dose increase or reduction is recommended based on individual safety and tolerability.
Det anbefales at NovoEight bruges straks efter rekonstitution.
NovoEight is recommended to be used immediately after it has been reconstituted.
Det anbefales at NovoThirteen til injektion anvendes straks efter klargøring.
Once prepared, NovoThirteen for injection should be used immediately.
Det anbefales at nylig behandlede dyr ikke sover sammen med deres ejere, især ikke med børn.
It is therefore recommended that recently treated animals do not sleep with owners, especially children.
Det anbefales at observere for infusionsreaktioner under og 2 timer efter infusion.
Observation for infusion reactions is recommended during and for 2 hours after LEMTRADA infusion.
Det anbefales at opblande lægemidlet med en lille mængde foder.
To be administered preferably mixed with a small quantity of feed.
Det anbefales at overvåge de biokemiske og metaboliske parameter under behandlingen med Stivarga og at indlede hensigtsmæssig substitutionsbehandling iht. almindelig klinisk praksis efter behov.
It is recommended to monitor biochemical and metabolic parameters during Stivarga treatment and to institute appropriate replacement therapy according to standard clinical practice if required.
Det anbefales at overvåge digoxin- niveauerne, når digoxin kombineres med Genvoya.
It is recommended that digoxin levels be monitored when digoxin is combined with Genvoya.
Det anbefales at overvåge digoxin- niveauerne, når digoxin kombineres med Stribild.
It is recommended that digoxin levels be monitored when digoxin is combined with Stribild.
Det anbefales at overvåge koncentrationsniveauerne hyppigt de 2 første uger efter transplantation og at følge op med periodisk overvågning under vedligeholdelsesbehandlingen.
Frequent trough level monitoring in the initial 2 weeks post transplantation is recommended, followed by periodic monitoring during maintenance therapy.
Det anbefales at overvåge koncentrationsniveauerne hyppigt de to første uger efter transplantation og at følge op med periodisk overvågning under vedligeholdelses- behandlingen.
Frequent trough level monitoring in the initial two weeks post transplantation is recommended, followed by periodic monitoring during maintenance therapy.
Det anbefales at overvåge kosten.
Dietary supervision is recommended.
Det anbefales at overvåge viral load hos disse patienter i løbet af den første måned efter behandlingen skiftes til Stribild.
Monitoring of viral load is recommended for these patients during the first month after switching treatment to Stribild.
Det anbefales at overvåges thyroideafunktionen efter en overdosis.
It is recommended to monitor thyroid function following an overdose.
Det anbefales at patienter som får cladribine, får bestrålede cellulære blodbestanddele/-produkter for at forebygge transfusionsrelateret graft-versus-host sygdom (Ta-GVHD).
It is recommended that patients receiving cladribine should receive irradiated cellular blood components/products to prevent transfusion-related graft-versus-host disease (Ta-GVHD).
Det anbefales at patienter, der har vist en grad af klinisk forbedring, ophører med ruxolitinib- behandlingen, hvis de bevarer en øgning i længden af milten på 40% sammenlignet med baselinestørrelse (ca. svarende til en 25% øgning i miltvolumen) og ikke længere har konkret forbedring af sygdomsrelaterede symptomer.
It is recommended that, for patients who have demonstrated some degree of clinical improvement, ruxolitinib therapy be discontinued if they sustain an increase in their spleen length of 40% compared with baseline size (roughly equivalent to a 25% increase in spleen volume) and no longer have tangible improvement in disease-related symptoms.
Det anbefales at patienterne nøje overvåges lægeligt under og mindst 30 minutter efter injektion af SonoVue.
It is recommended to keep the patient under close medical supervision during and for at least 30 minutes following the administration of SonoVue.
Det anbefales at påbegynde infusionen med en hastighed på 1 mg/kg/t og øge den gradvis med 2 mg/kg/t hver 30. minut, hvis der ikke er tegn på infusionsrelaterede reaktioner, op til maksimalt 7 mg/kg/t.
It is recommended that the infusion begin at an initial rate of 1 mg/kg/h and be gradually increased by 2 mg/kg/h every 30 minutes if there are no signs of IARs (Infusion Associated Reactions) until a maximum rate of 7 mg/kg/h is reached.
Det anbefales at reducere dosis af tolvaptan for patienter, mens de tager moderate eller stærke CYP3A-hæmmere (se pkt.
Dose reduction of tolvaptan is recommended for patients while taking moderate or strong CYP3A
Det anbefales at rekonstitueret Visudyne inspiceres visuelt for partikler og misfarvning umiddelbart før anvendelse.
It is recommended that reconstituted Visudyne be inspected visually for particulate matter and discoloration prior to administration.
Det anbefales at rense og tørre den ydre øregang før behandling, og overskydende hårvækst omkring behandlingsområdet bør afklippes.
It is recommended that the external ear canal should be cleaned and dried before treatment and excess hair around the treatment area be cut.
Det anbefales at seponere behandling med stoffer, der påvirker hæmostase, inden behandling med enoxaparin, medmindre brugen af disse er afgørende, f.eks.: systemiske salicylater, ASA, NSAID inklusive ketorolac, dextran og clopidogrel, systemiske glukokortikoider, trombolytika og antikoagulantia samt andre trombocytfunktionshæmmende midler, herunder glykoprotein IIb-/IIIa- antagonister.
It is recommended that agents which affect haemostasis should be discontinued prior to enoxaparin therapy unless their use is essential, such as: systemic salicylates, ASA, NSAIDs including ketorolac, dextran, and clopidogrel, systemic glucocorticoids, thrombolytics and anticoagulants, and other antiplatelet agents, including glycoprotein IIb/IIIa antagonists.
Det anbefales at seponere behandling med stoffer, der påvirker hæmostase, inden behandling med enoxaparin, medmindre brugen af disse er vigtig, f.eks.: systemiske salicylater, ASA, NSAID inklusive ketorolac, dextran og clopidogrel, systemiske glukokortikoider, trombolytika og antikoagulantia samt andre trombocytfunktionshæmmende midler, herunder glykoprotein IIb-/IIIa- antagonister.
It is recommended that agents which affect haemostasis should be discontinued prior to enoxaparin therapy unless their use is essential, such as: systemic salicylates, ASA, NSAIDs including ketorolac, dextran, and clopidogrel, systemic glucocorticoids, thrombolytics and anticoagulants, and other antiplatelet agents, including glycoprotein IIb/IIIa antagonists.
Det anbefales at seponere behandling med stoffer, der påvirker hæmostasen, inden behandling med enoxaparin, medmindre brugen af disse er vigtig, f.eks.: systemiske salicylater, ASA, NSAID inklusive ketorolac, dextran og clopidogrel, systemiske glukokortikoider, trombolytika og antikoagulantia samt andre trombocytfunktionshæmmende midler, herunder glykoprotein IIb-/IIIa- antagonister.
It is recommended that agents which affect haemostasis should be discontinued prior to enoxaparin therapy unless their use is essential, such as: systemic salicylates, ASA, NSAIDs including ketorolac, dextran, and clopidogrel, systemic glucocorticoids, thrombolytics and anticoagulants, and other antiplatelet agents, including glycoprotein IIb/IIIa antagonists.
Det anbefales at seponere behandlingen hos alle patienter med hcv-RNA-koncentration højere end eller lig med 1.000 IE/ml i behandlingsuge 8, eller hcv-RNA-koncentration højere end eller lig med 100 IE/ml i behandlingsuge 12, eller bekræftet, detekterbart hcv-RNA i behandlingsuge 24.
Discontinuation of therapy is recommended in all patients with 1) HCV-RNA levels of greater than or equal to 1,000 IU per mL at TW 8; or 2) HCV-RNA levels of greater than or equal to 100 IU per mL at TW 12; or 3) confirmed, detectable HCV-RNA levels at TW 24.
Det anbefales at seponere behandlingen med trastuzumabemtansin permanent hos patienter, der diagnosticeres med interstitiel lungesygdom eller pneumonitis.
It is recommended that treatment with trastuzumab emtansine be permanently discontinued in patients who are diagnosed with ILD or pneumonitis.
Det anbefales at skrive datoen for den første injektion på hætteglassets etiket.
It is recommended that the date of the first use be noted on the label.
Det anbefales at skrive den dato på emballagen, hvor flasken tages ud af køleskabet.
It is advised to write the date of removal from the refrigerator on the package.
Det anbefales at starte et kost- og motions- program før indledning af behandling med alli.
It is recommended that a diet and exercise programme is started before beginning treatment with alli.
Det anbefales at starte med 1,0 ME (10 mikrogram) filgrastim /kg/dag.
The recommended starting dose of filgrastim is 1.0 MU (10 micrograms)/kg/day.
Det anbefales at stoppe behandlingen med Raptiva, hvis arthritis forekommer under behandlingen.
It is recommended to discontinue Raptiva if arthritis occurs during treatment.
Det anbefales at stoppe behandlingen, hvis trombocyttallet falder til <25.000/mm3.
Cessation of therapy is recommended when platelet count decreases to levels < 25,000/mm3.
Det anbefales at sætte Caelyx-infusionsslangen som sidedrop til en intravenøs infusion med 5 % (50 mg/ml) glucose.
It is recommended that the Caelyx infusion line be connected through the side port of an intravenous infusion of 5% (50 mg/ml) glucose.
Det anbefales at tabletten ikke deles, knuses eller tygges.
It is recommended that the tablet should not be split, crushed or chewed.
Det anbefales at tage Efavirenz Teva på tom mave, helst ved sengetid.
It is recommended to be taken on an empty stomach preferably at bedtime.
Det anbefales at tage passende forholdsregler vedr. kontraception i 12 uger efter seponering, da efavirenz har en lang halveringstid.
Because of the long half-life of efavirenz, use of adequate contraceptive measures for 12 weeks after discontinuation of efavirenz is recommended.
Det anbefales at tage Stocrin på tom mave, helst ved sengetid.
Stocrin is recommended to be taken on an empty stomach prefereably at bedtime.
Det anbefales at teste individuelt respons på cargluminsyre, inden der indledes længevarende behandling.
It is recommended to test individual responsiveness to carglumic acid before initiating any long term treatment.
Det anbefales at tildække applikationsstedet med tøj, så snart gelen er tørret ind.
It is recommended to cover the application site with clothing once the gel has dried.
Det anbefales at tilsætte vand til injektionsvæsker forsigtigt langs hætteglassets væg for at undgå kraftig skumdannelse.
To avoid excessive foaming, it is recommended that WFI should be added carefully, along the walls of the vials.
Det anbefales at udføre en kardiovaskulær undersøgelse, herunder baseline-EKG og baseline- ekkokardiografi, hos alle patienter, før behandlingen med anagrelid påbegyndes.
A pre-treatment cardiovascular examination, including a baseline ECG and echocardiography is recommended for all patients prior to initiating therapy with anagrelide.
Det anbefales at udføre en test for tilstedeværelse af Leishmaniose-infektion før vaccination ved at bruge en hurtig serologisk diagnostisk test.
The detection of Leishmania infection using a rapid serological diagnostic test is recommended prior to vaccination.
Det anbefales at udføre månedlige graviditetsprøver med henblik på tidlig konstatering af graviditet.
Monthly pregnancy tests are recommended during treatment to allow early detection of pregnancy
Det anbefales at udføre samme første-dosis-monitorering som ved behandlingsstart, når behandling har været afbrudt i:
The same first dose monitoring as for treatment initiation is recommended when treatment is interrupted for:
Det anbefales at udsætte vaccinationen til efter en sådan behandling eller sygdom.
It is recommended to postpone vaccination until the end of such treatment or disease.
Det anbefales at udvise forsigtighed hos patienter i behandling med antikoagulantia og/eller lægemidler (f.eks.
Caution is advised in patients taking anticoagulants and/or medicinal products known to affect platelet function (e.g.
Det anbefales at udvise forsigtighed hos patienter i behandling med antikoagulantika og/eller lægemidler (f.eks.
Caution is advised in patients taking anticoagulants and/or medicinal products known to affect platelet function (e.g.
Det anbefales at udvise forsigtighed ved administration af ARICLAIM sammen med præparater, som hovedsageligt metaboliseres via CYP2D6 (risperidon, tricycliske antidepressiva [TCA’er] såsom nortriptylin, amitriptylin og imipramin), specielt hvis disse præparater har et snævert terapeutisk indeks (som f.eks. flecainid, propafenon og metoprolol).
Caution is advised if ARICLAIM is co-administered with medicinal products that are predominantly metabolised by CYP2D6 (risperidone, tricyclic antidepressants [TCAs] such as nortriptyline, amitriptyline, and imipramine) particularly if they have a narrow therapeutic index (such as flecainide, propafenone and metoprolol).
Det anbefales at udvise forsigtighed ved administration af Cymbalta sammen med præparater, som hovedsageligt metaboliseres via CYP2D6 (risperidon, tricycliske antidepressiva [TCA’er] såsom nortriptylin, amitriptylin og imipramin), specielt hvis disse præparater har et snævert terapeutisk indeks (som f.eks. flecainid, propafenon og metoprolol).
Caution is advised if Cymbalta is co-administered with medicinal products that are predominantly metabolised by CYP2D6 (risperidone, tricyclic antidepressants [TCAs] such as nortriptyline, amitriptyline, and imipramine) particularly if they have a narrow therapeutic index (such as flecainide, propafenone and metoprolol).
Det anbefales at udvise forsigtighed ved administration af Duloxetin Lilly sammen med præparater, som hovedsageligt metaboliseres via CYP2D6 (risperidon, tricycliske antidepressiva [TCA’er] såsom nortriptylin, amitriptylin og imipramin), specielt hvis disse præparater har et snævert terapeutisk indeks (som f.eks. flecainid, propafenon og metoprolol).
Caution is advised if Duloxetine Lilly is co-administered with medicinal products that are predominantly metabolised by CYP2D6 (risperidone, tricyclic antidepressants [TCAs] such as nortriptyline, amitriptyline, and imipramine) particularly if they have a narrow therapeutic index (such as flecainide, propafenone and metoprolol).
Det anbefales at udvise forsigtighed ved administration af duloxetin sammen med præparater, som hovedsageligt metaboliseres via CYP2D6 (risperidon, tricycliske antidepressiva [TCA’er] såsom nortriptylin, amitriptylin og imipramin), specielt hvis disse præparater har et snævert terapeutisk indeks (som f.eks. flecainid, propafenon og metoprolol).
Caution is advised if duloxetine is co-administered with medicinal products that are predominantly metabolised by CYP2D6 (risperidone, tricyclic antidepressants [TCAs] such as nortriptyline, amitriptyline, and imipramine) particularly if they have a narrow therapeutic index (such as flecainide, propafenone and metoprolol).
Det anbefales at udvise forsigtighed ved administration af duloxetin sammen med præparater, som hovedsageligt metaboliseres via CYP2D6 (risperidon, tricycliske antidepressiva [TCA’er] såsom nortriptylin, amitriptylin og imipramin), specielt hvis disse præparater har et snævert terapeutisk indeks (som f.eks. flecainid, propafenon og metoprolol).
Caution is advised if YENTREVE is co-administered with medicinal products that are predominantly metabolised by CYP2D6 (risperidone, tricyclic antidepressants [TCAs] such as nortriptyline, amitriptyline, and imipramine) particularly if they have a narrow therapeutic index (such as flecainide, propafenone and metoprolol).
Det anbefales at udvise forsigtighed ved administration af DULOXETINE BOEHRINGER INGELHEIM sammen med præparater, som hovedsageligt metaboliseres via CYP2D6 (risperidon, tricycliske antidepressiva [TCA’er] såsom nortriptylin, amitriptylin og imipramin), specielt hvis disse præparater har et snævert terapeutisk indeks (som f.eks. flecainid, propafenon og metoprolol).
Caution is advised if DULOXETINE BOEHRINGER INGELHEIM is co-administered with medicinal products that are predominantly metabolised by CYP2D6 (risperidone, tricyclic antidepressants [TCAs] such as nortriptyline, amitriptyline, and imipramine) particularly if they have a narrow therapeutic index (such as flecainide, propafenone and metoprolol).
Det anbefales at udvise forsigtighed ved administration af Duloxetine Mylan sammen med præparater, som hovedsageligt metaboliseres via CYP2D6 (risperidon, tricycliske antidepressiva [TCA’er] såsom nortriptylin, amitriptylin og imipramin), specielt hvis disse præparater har et snævert terapeutisk indeks (som f.eks. flecainid, propafenon og metoprolol).
Caution is advised if Duloxetine Mylan is co-administered with medicinal products that are predominantly metabolised by CYP2D6 (risperidone, tricyclic antidepressants [TCAs] such as nortriptyline, amitriptyline, and imipramine) particularly if they have a narrow therapeutic index (such as flecainide, propafenone and metoprolol).
Det anbefales at udvise forsigtighed ved administration af Xeristar sammen med præparater, som hovedsageligt metaboliseres via CYP2D6 (risperidon, tricycliske antidepressiva [TCA’er] såsom nortriptylin, amitriptylin og imipramin), specielt hvis disse præparater har et snævert terapeutisk indeks (som f.eks. flecainid, propafenon og metoprolol).
Caution is advised if Xeristar is co-administered with medicinal products that are predominantly metabolised by CYP2D6 (risperidone, tricyclic antidepressants [TCAs] such as nortriptyline, amitriptyline, and imipramine) particularly if they have a narrow therapeutic index (such as flecainide, propafenone and metoprolol).
Det anbefales at udvise forsigtighed, hvis ARICLAIM anvendes sammen med serotonerge lægemidler som SSRI- præparater, SNRI-præparater, tricykliske antidepressiva (f.eks. clomipramin eller amitriptylin), MAOI’er som moclobemid eller linezolid, perikon (hypericum perforatum) eller triptaner, tramadol, pethidin og tryptophan(se afsnit 4.4).
Caution is advisable if ARICLAIM is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Det anbefales at udvise forsigtighed, hvis ARICLAIM anvendes sammen med serotonerge lægemidler som SSRI- præparater, SNRI-præparater, tricykliske antidepressiva (f.eks. clomipramin eller amitriptylin), MAOI’er som moclobemid eller linezolid, perikon (hypericum perforatum) eller triptaner, tramadol, pethidin og tryptophan(se afsnit 4.4).
Caution is advisable if ARICLAIM is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum), or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Det anbefales at udvise forsigtighed, hvis Cymbalta anvendes sammen med serotonerge lægemidler som SSRI-præparater, SNRI-præparater, tricykliske antidepressiva (f.eks. clomipramin eller amitriptylin), MAOI’er som moclobemid eller linezolid, perikon (Hypericum perforatum) eller triptaner, tramadol, pethidin og tryptophan (se afsnit 4.4).
Caution is advisable if Cymbalta is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Det anbefales at udvise forsigtighed, hvis Duloxetin Lilly anvendes sammen med serotonerge lægemidler som SSRI- præparater, SNRI-præparater, tricykliske antidepressiva (f.eks. clomipramin eller amitriptylin), MAOI’er som moclobemid eller linezolid, perikon (Hypericum perforatum) eller triptaner, tramadol, pethidin og tryptophan (se afsnit 4.4).
Caution is advisable if Duloxetine Lilly is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Det anbefales at udvise forsigtighed, hvis DULOXETINE BOEHRINGER INGELHEIM anvendes sammen med serotonerge antidepressiva som SSRI-præparater, tricykliske præparater (f.eks. clomipramin eller amitriptylin), perikon (hypericum perforatum), venlafaxin eller triptaner, tramadol, pethidin og tryptophan.
Caution is advisable if DULOXETINE BOEHRINGER INGELHEIM is used concomitantly with serotonergic antidepressants like SSRIs, tricyclics like clomipramine or amitriptyline, St John’s wort (Hypericum perforatum), venlafaxine or triptans, tramadol, pethidine and tryptophan.
Det anbefales at udvise forsigtighed, hvis Duloxetine Mylan anvendes sammen med serotonerge lægemidler som SSRI- præparater, SNRI-præparater, tricykliske antidepressiva (f.eks. clomipramin eller amitriptylin), MAOI’er som moclobemid eller linezolid, perikon (Hypericum perforatum) eller triptaner, tramadol, pethidin og tryptophan (se afsnit 4.4).
Caution is advisable if Duloxetine Mylan is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Det anbefales at udvise forsigtighed, hvis Xeristar anvendes sammen med serotonerge lægemidler som SSRI- præparater, SNRI-præparater, tricykliske antidepressiva (f.eks. clomipramin eller amitriptylin), MAOI’er som moclobemid eller linezolid, perikon (Hypericum perforatum) eller triptaner, tramadol, pethidin og tryptophan (se afsnit 4.4).
Caution is advisable if Xeristar is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Det anbefales at udvise særlig opmærksomhed over for patienter med nedsat kapacitet og allerede eksisterende cardiopulmonær sygdom.
Special attention is recommended for patients with reduced performance status and pre-existing cardio- pulmonary disease.
Det anbefales at undlade amning, når du tager Zalviso.
Breastfeeding is not recommended when you take Zalviso.
Det anbefales at undlade at amme i 6 måneder efter afslutning af behandling med dette lægemiddel.
The recommended interval time between treatment discontinuation and breastfeeding is 6 months.
Det anbefales at vaccinere alle dyr i besætningen på samme tidspunkt.
It is advisable to vaccinate all the animals in the herd at the same time.
Det anbefales at vaccinere før drægtighed for at sikre beskyttelse mod persistent infektion af fosteret.
It is recommended to vaccinate before pregnancy to ensure protection againt persistent infection of the foetus.
Det anbefales at vaccinere gravide kvinder med sygdomme, der øger risikoen for at få komplikationer i forbindelse med influenza, uanset hvor langt henne i graviditeten de er.
For pregnant women with medical conditions that increase their risk of complications from the flu, administration of the vaccine is recommended, irrespective of their stage of pregnancy.
Det anbefales at vaccinere på steder, hvor RHDV2 er epidemiologisk relevant.
Vaccination is recommended where RHDV2 is epidemiologically relevant.